NCT02929316View on ClinicalTrials.gov

Vedolizumab Induction May Prevent Celiac Enteritis

PHASE2TerminatedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

June 25, 2018

Primary Completion Date

October 5, 2018

Study Completion Date

October 5, 2018

Conditions
Celiac Disease
Interventions
DRUG

Vedolizumab

IV infusion week 0, 2 and 6

Trial Locations (2)

08234

AGA Clinical Research Associates, LLC, Egg Harbor

Theresa Stevens, Egg Harbor

Sponsors

Collaborators (1)

Takeda
All Listed Sponsors
collaborator

Takeda

INDUSTRY

lead

AGA Clinical Research Associates, LLC

OTHER